First‐Time‐in‐Human Dose Selection: Allometric Thoughts and Perspectives
暂无分享,去创建一个
[1] U. Thorgeirsson,et al. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. , 1976, Annals of internal medicine.
[2] I. Otterness,et al. Nonsteroidal anti-inflammatory drugs: an analysis of the relationship between laboratory animal and clinical doses, including species scaling. , 1988, Journal of pharmaceutical sciences.
[3] M Slavik,et al. Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. , 1975, Cancer research.
[4] W. Calder. Size, Function, and Life History , 1988 .
[5] Willard R. Chappell,et al. Extrapolation of Toxicological and Pharmacological Data from Animals to Humans , 1991 .
[6] L. J. West,et al. Lysergic Acid Diethylamide: Its Effects on a Male Asiatic Elephant. , 1962, Science.
[7] W. Barker. Ontogeny and phylogeny. , 1980, Archives of surgery.
[8] T. Clutton‐Brock,et al. LIFE HISTORY VARIATION IN PRIMATES , 1985, Evolution; international journal of organic evolution.
[9] Brian T. Shea,et al. Heterochrony in human evolution: The case for neoteny reconsidered , 1989 .
[10] P. N. Kugler,et al. Similarity principles and intrinsic geometries: contrasting approaches to interspecies scaling. , 1986, Journal of pharmaceutical sciences.
[11] H. Boxenbaum,et al. Interspecies pharmacokinetic scaling, biological design and neoteny , 1990 .
[12] B. Chabner,et al. Potential roles for preclinical pharmacology in phase I clinical trials. , 1986, Cancer treatment reports.
[13] K H Antonin,et al. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. , 1976, The Journal of pharmacology and experimental therapeutics.
[14] Henry D. Prange,et al. Scaling of Skeletal Mass to Body Mass in Birds and Mammals , 1979, The American Naturalist.
[15] J. Litchfield. Forecasting drug effects in man from studies in laboratory animals. , 1961, JAMA.
[16] P. D. Harwood. Therapeutic Dosage in Small and Large Mammals. , 1963, Science.
[17] P. Abelson. Incorporation of new science into risk assessment , 1990, Science.
[18] J. Haldane. Possible Worlds, and other Essays , 1928, Nature.
[19] E. Richelson,et al. Binding of benzodiazepines and some major metabolites at their sites in normal human frontal cortex in vitro. , 1991, The Journal of pharmacology and experimental therapeutics.
[20] W. R. Stahl,et al. Scaling of respiratory variables in mammals. , 1967, Journal of applied physiology.
[21] E J Freireich,et al. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.
[22] Scaling of bodily proportions in adult terrestrial mammals. , 1992, The American journal of physiology.
[23] J. Prothero,et al. Scaling of blood parameters in mammals , 1980 .
[24] J. Caldwell,et al. The current status of attempts to predict species differences in drug metabolism. , 1981, Drug metabolism reviews.
[25] J. Mordenti. Dosage regimen design for pharmaceutical studies conducted in animals. , 1986, Journal of pharmaceutical sciences.
[26] A. Sedman,et al. New Drugs: First Time in Man , 1989, Journal of clinical pharmacology.
[27] W. Colburn. Controversy V: Phase I, First Time in Man Studies , 1990, Journal of clinical pharmacology.
[28] K. Bergmann,et al. Handbook of the biology of aging , 1979 .